Trending...
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Digital Watchdog Launches New myDW Cloud Services
LAS VEGAS, May 21, 2020 /PRNewswire/ -- Biopharmaceutical company EUCYT announced Tammy C. Luttrell, MSPT, Ph.D., CWS, FCCWS, has been promoted to Chief Scientific Officer. Luttrell's advancement follows her initial stint as Vice President of Product Development beginning last August.
The promotion also highlights EUCYT's commitment to encouraging the need for more women to join science, technology, engineering and mathematics (STEM) careers.
"I'm truly blessed to be part of such a wonderful team here in Las Vegas. This is a fabulous opportunity for me personally and for our city and university partners," said Luttrell. "With the EUCYT proprietary technology platform, we have the opportunity to truly bring bench science to the bedside and significantly improve the quality of life for patients and, at the same time, continue to push the forefront of applied science. Biological science will pave the way for continued improvement in medicine. It will allow me to focus even more intensely on the wonderful advancements our company is making in generative medicine and health. I also hope it shows just how much of a contribution women can make in STEM careers and encourage them to seek out such roles."
More on nvtip.com
Luttrell brings more than 30 years' experience, in international regenerative medicine research, primarily in the trauma, burn and wound care space. As the Chief Scientific Officer, she will continue leading EUCYT's important development of a potential treatment for COVID-19-positive patients called COVIXO.
COVIXO is a mesenchymal stem-cell-derived therapy that harnesses the power of the immune system to augment the body's natural response to invading pathogens such as severe acute respiratory syndrome coronavirus 2, the causative agent behind COVID-19. For information visit: https://eucyt.com/wp-content/uploads/2020/03/covixo.pdf.
"This promotion shows just how important Dr. Luttrell's contributions have been to a potential treatment for COVID-19 and the EUCYT team's projects in general," said Chief Executive Officer, Travis H. Bird. "She brings three decades of wound and burn care emphasis which is a perfect complement to the regenerative medicine work we're doing to define the future of and heal patients, not just treat them."
Luttrell's extensive career includes helping revamp inner-city Las Vegas' Sunrise Hospital and Medical Center's RESTORE Wound Care Center/BRCA Burn Unit. She also is a physical therapy doctoral program adjunct faculty member at Colorado University in Denver and has owned her own consulting firm since 2000, where she handles special projects for the states of Colorado and Arkansas, including legal medical case reviews, wound center consultations and staff trainings. She also provides educational presentations and lectures domestically and internationally pertaining to wound healing and skin diseases.
More on nvtip.com
About EUCYT
EUCYT is a biopharmaceutical company focusing on precision healthcare by harnessing the power within the human body to change the way people heal. EUCYT is committed to delivering safe, effective, leading-edge, advanced biologic technology.
Inquiries should be directed to Denise Bird, Director, Marketing and Sponsorships, 833.693.8298 or [email protected]
www.eucyt.com
Related Links
Follow Us on Facebook
Follow Us on Twitter
SOURCE EUCYT
Related Links
http://www.eucyt.com
The promotion also highlights EUCYT's commitment to encouraging the need for more women to join science, technology, engineering and mathematics (STEM) careers.
"I'm truly blessed to be part of such a wonderful team here in Las Vegas. This is a fabulous opportunity for me personally and for our city and university partners," said Luttrell. "With the EUCYT proprietary technology platform, we have the opportunity to truly bring bench science to the bedside and significantly improve the quality of life for patients and, at the same time, continue to push the forefront of applied science. Biological science will pave the way for continued improvement in medicine. It will allow me to focus even more intensely on the wonderful advancements our company is making in generative medicine and health. I also hope it shows just how much of a contribution women can make in STEM careers and encourage them to seek out such roles."
More on nvtip.com
- Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
Luttrell brings more than 30 years' experience, in international regenerative medicine research, primarily in the trauma, burn and wound care space. As the Chief Scientific Officer, she will continue leading EUCYT's important development of a potential treatment for COVID-19-positive patients called COVIXO.
COVIXO is a mesenchymal stem-cell-derived therapy that harnesses the power of the immune system to augment the body's natural response to invading pathogens such as severe acute respiratory syndrome coronavirus 2, the causative agent behind COVID-19. For information visit: https://eucyt.com/wp-content/uploads/2020/03/covixo.pdf.
"This promotion shows just how important Dr. Luttrell's contributions have been to a potential treatment for COVID-19 and the EUCYT team's projects in general," said Chief Executive Officer, Travis H. Bird. "She brings three decades of wound and burn care emphasis which is a perfect complement to the regenerative medicine work we're doing to define the future of and heal patients, not just treat them."
Luttrell's extensive career includes helping revamp inner-city Las Vegas' Sunrise Hospital and Medical Center's RESTORE Wound Care Center/BRCA Burn Unit. She also is a physical therapy doctoral program adjunct faculty member at Colorado University in Denver and has owned her own consulting firm since 2000, where she handles special projects for the states of Colorado and Arkansas, including legal medical case reviews, wound center consultations and staff trainings. She also provides educational presentations and lectures domestically and internationally pertaining to wound healing and skin diseases.
More on nvtip.com
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- BOXABL Launches Search for New Directors and Executive Leadership
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- Circus Circus Las Vegas Debuts Summer Pricing for Adventuredome, Carnival Midway
About EUCYT
EUCYT is a biopharmaceutical company focusing on precision healthcare by harnessing the power within the human body to change the way people heal. EUCYT is committed to delivering safe, effective, leading-edge, advanced biologic technology.
Inquiries should be directed to Denise Bird, Director, Marketing and Sponsorships, 833.693.8298 or [email protected]
www.eucyt.com
Related Links
Follow Us on Facebook
Follow Us on Twitter
SOURCE EUCYT
Related Links
http://www.eucyt.com
Filed Under: Business
0 Comments
Latest on nvtip.com
- Digital Watchdog Launches New myDW Cloud Services
- Nevada Real Estate Agent David Crane Helping Families Find Their Dream Home
- Stan Fitzgerald Appointed Acting Press Secretary for Veterans for America First VFAF Georgia State Chapter
- Drone Light Shows Emerge as the New Standard in Live Event Entertainment
- Lore Link is Here to Help Organize Your Game
- Chappaqua's Annual Townwide Summer Sale – Unbeatable Savings at Your Favorite Local Boutiques!
- Inside the Mind of an Investor: What They Look for in a Business Plan
- Skyline Partners with ZenSpace to Offer Private Meeting Pods for Trade Show Exhibitors
- AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
- Construcción del Corredor Norte–Sur (NSC) de Singapur
- New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road